Ground Swell Capital’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Ground Swell Capital’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$7K	Buy	+200	New	+$7.04K	0.01%	1304

Other funds holding KYTH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Ground Swell Capital's KYTH Position: Q3 2014 in Review

Ground Swell Capital opened a new position in KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q3 2014: 200 shares worth $7K. The stake represents 0.01% of the portfolio and ranks #1304 among its holdings.

110 funds tracked by Wall St. Rank hold KYTH as of Q3 2014.

Ground Swell Capital held 200 shares of KYTHERA BIOPHARMACEUTICALS, INC COM worth $7K as of Q3 2014.
KYTHERA BIOPHARMACEUTICALS, INC COM was a new Ground Swell Capital position in Q3 2014.
KYTHERA BIOPHARMACEUTICALS, INC COM made up 0.01% of Ground Swell Capital's portfolio in Q3 2014, its #1304 holding.
110 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.